PDEX Pro Dex Inc

Price (delayed)

$18.75

Market cap

$65.84M

P/E Ratio

13.3

Dividend/share

N/A

EPS

$1.41

Enterprise value

$78.04M

Pro-Dex, Inc. specializes in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and maxocranial facial markets. It ...

Highlights
The quick ratio has surged by 72% year-on-year and by 21% since the previous quarter
PDEX's equity is up by 30% year-on-year
PDEX's P/E is 39% above its last 4 quarters average of 9.4 but 5% below its 5-year quarterly average of 13.8
Pro Dex's debt has decreased by 7% YoY but it has increased by 4.2% QoQ
Pro Dex's EPS has decreased by 31% QoQ and by 23% YoY
PDEX's net income is down by 31% since the previous quarter and by 23% year-on-year

Key stats

What are the main financial stats of PDEX
Market
Shares outstanding
3.51M
Market cap
$65.84M
Enterprise value
$78.04M
Valuations
Price to earnings (P/E)
13.3
Price to book (P/B)
2.09
Price to sales (P/S)
1.38
EV/EBIT
10.69
EV/EBITDA
9.36
EV/Sales
1.62
Earnings
Revenue
$48.24M
EBIT
$7.3M
EBITDA
$8.34M
Free cash flow
$3.02M
Per share
EPS
$1.41
Free cash flow per share
$0.85
Book value per share
$8.96
Revenue per share
$13.6
TBVPS
$14.48
Balance sheet
Total assets
$51.43M
Total liabilities
$19.64M
Debt
$13.49M
Equity
$31.79M
Working capital
$26.61M
Liquidity
Debt to equity
0.42
Current ratio
3.66
Quick ratio
2.03
Net debt/EBITDA
1.46
Margins
EBITDA margin
17.3%
Gross margin
28.3%
Net margin
10.4%
Operating margin
13%
Efficiency
Return on assets
10%
Return on equity
16.6%
Return on invested capital
14%
Return on capital employed
17.6%
Return on sales
15.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PDEX stock price

How has the Pro Dex stock price performed over time
Intraday
0%
1 week
2.68%
1 month
7.82%
1 year
15.38%
YTD
7.02%
QTD
6.84%

Financial performance

How have Pro Dex's revenue and profit performed over time
Revenue
$48.24M
Gross profit
$13.63M
Operating income
$6.29M
Net income
$5M
Gross margin
28.3%
Net margin
10.4%
PDEX's operating income is up by 46% year-on-year but it is down by 5% since the previous quarter
PDEX's operating margin is up by 34% YoY but it is down by 8% QoQ
Pro Dex's net margin has decreased by 33% QoQ and by 30% YoY
PDEX's net income is down by 31% since the previous quarter and by 23% year-on-year

Growth

What is Pro Dex's growth rate over time

Valuation

What is Pro Dex stock price valuation
P/E
13.3
P/B
2.09
P/S
1.38
EV/EBIT
10.69
EV/EBITDA
9.36
EV/Sales
1.62
PDEX's P/E is 39% above its last 4 quarters average of 9.4 but 5% below its 5-year quarterly average of 13.8
Pro Dex's EPS has decreased by 31% QoQ and by 23% YoY
PDEX's price to book (P/B) is 41% lower than its 5-year quarterly average of 3.5 but 3% higher than its last 4 quarters average of 2.0
PDEX's equity is up by 30% year-on-year
The stock's price to sales (P/S) is 33% less than its 5-year quarterly average of 2.0 but 3.8% more than its last 4 quarters average of 1.3
PDEX's revenue is up by 9% YoY and by 2.8% QoQ

Efficiency

How efficient is Pro Dex business performance
The return on equity has declined by 39% year-on-year and by 35% since the previous quarter
Pro Dex's return on assets has decreased by 32% QoQ and by 28% YoY
Pro Dex's return on sales has decreased by 32% QoQ and by 24% YoY
Pro Dex's ROIC has decreased by 31% from the previous quarter and by 22% YoY

Dividends

What is PDEX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PDEX.

Financial health

How did Pro Dex financials performed over time
The total assets is 162% greater than the total liabilities
The quick ratio has surged by 72% year-on-year and by 21% since the previous quarter
Pro Dex's current ratio has increased by 36% YoY but it has decreased by 3.4% QoQ
Pro Dex's debt is 58% lower than its equity
PDEX's equity is up by 30% year-on-year
Pro Dex's debt to equity has decreased by 29% YoY but it has increased by 2.4% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.